Sidley Austin advised Healthcare Royalty on the deal. HealthCare Royalty, a leading royalty acquisition company, announced its US$250 million non-dilutive note purchase agreement with OPKO Health,...
HealthCare Royalty’s $250 Million Note Purchase Agreement With OPKO Health
HealthCare Royalty Partners’ Revenue Financing Agreement with Spero Therapeutics
Cadwalader advised HealthCare Royalty Partners on the deal. HealthCare Royalty Partners closed a revenue financing agreement for up to $125 million for Spero Therapeutics, Inc. (NASDAQ: SPRO),...